Closed System Architectures for One Pot Molecular Diagnostics

This direction is merged into another direction: isothermal nucleic acid amplification. Its last version stays readable and citable here.

Version 1 of 121 papers33 conceptsfrozen 2026-10-04

The central challenge of modern molecular diagnostics is a paradox of sensitivity: as our tools become better at detecting a single molecule of DNA, they become increasingly vulnerable to the "noise" of their own success. In the quest to move diagnostic testing out of specialized laboratories and into the field, researchers have converged on a shared strategy: the one-pot, closed-system reaction.

This approach integrates nucleic acid amplification and detection into a single, sealed environment, preventing the escape of synthetic genetic material that otherwise leads to catastrophic false positives.

The Amplicon Contamination Crisis

To detect a pathogen like SARS-CoV-2 or Salmonella, molecular assays must first "amplify" the target genetic material, creating billions of identical copies called amplicons. In traditional laboratory settings, this process is often "two-pot": the DNA is amplified in one tube, then the tube is opened to transfer the product to a second vessel for detection (such as a lateral flow strip or a sequencer).

The moment that tube is opened, amplicons can aerosolize and settle on laboratory surfaces, equipment, or even the breath of the researcher. Because assays are designed to be ultra-sensitive—for instance, the Ascaris assay developed by Nils Pilotte is 3,100 times more sensitive than previous standards—even a single stray amplicon from a previous test can trigger a false positive in a new sample.

This is not a theoretical risk. David M. Irlbeck and colleagues demonstrated that high-profile links between Chronic Fatigue Syndrome and murine viruses were actually the result of trace DNA contamination in common laboratory reagents. Similarly, Yi‐Hua Zhou found that reported rates of occult Hepatitis B were often artifacts of cross-contamination rather than clinical reality.

The One Pot Solution

To solve this, researchers like Julia Joung and Alim Ladha developed STOPCovid, a "one-pot" diagnostic. By combining isothermal amplification (LAMP) with CRISPR-based detection in a single vessel, the entire process—from raw sample to result—occurs without ever opening the tube.

The intuition behind the one-pot system is simple: containment through synchronization. For this to work, the amplification enzymes (which copy the DNA) and the detection enzymes (like Cas12 or Cas13, which "sense" the DNA) must be compatible. Ahmed Mahas and Rashid Aman achieved this by identifying thermophilic CRISPR enzymes that function at the same high temperatures as isothermal amplification, allowing both reactions to run simultaneously in a "closed-system architecture."

Physical Separation and Mechanical Initiation

A recurring hurdle in one-pot design is that the detection reagents can sometimes interfere with the amplification phase if they are mixed too early. Researchers have developed clever mechanical workarounds to maintain a "sequential" reaction within a single sealed vessel.

Mengyu Wang and Xujing Wang pioneered a lid-based separation technique. In their system, the amplification reagents sit at the bottom of the tube, while the CRISPR detection reagents are housed in the lid. After the first phase is complete, the user simply inverts the tube to mix the components. This maintains the integrity of a closed system while ensuring the two chemical processes do not "clash."

From Clean Rooms to the Field

The ultimate goal of this research direction is to make molecular testing "field-deployable." Standard PCR requires expensive thermal cyclers and sterile clean rooms to manage contamination. By contrast, closed systems like the iLACO platform described by Lin Yu or the MERS-CoV assay by Hongli Jin allow for high-accuracy testing in non-sterile environments.

Even in high-end clinical settings, the shift toward closed systems is improving reliability. Chad Vanderbilt and Rusmir Feratovic found that processing "scant" cancer cytology samples in closed-tube systems significantly reduced the risk of DNA carryover compared to traditional open-air tissue processing.

By treating the reaction vessel as a biological "black box" that is never opened after amplification begins, these researchers are transforming molecular diagnostics from a fragile laboratory art into a robust, portable technology. As Na Li demonstrates with recent work on fish viruses, these one-pot systems—often lyophilized into shelf-stable pellets—represent the future of decentralized, high-sensitivity biosensing.

Papers in this version

History & citationVersion 1 · 2026-10-04

Merged into another direction · Permanent link

View frozen version 1

Cite this direction

Latest version (a living page):

@misc{lacuna_closed_system_architectures_for_one_pot__0e43a30b,
  title = {Closed System Architectures for One Pot Molecular Diagnostics},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/closed-system-architectures-for-one-pot-molecular-diagnostics/rdr_0e43a30b98e64127954d3f2f99040948},
  note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}

This exact version (version 1, frozen text):

@misc{lacuna_closed_system_architectures_for_one_pot__0e43a30b_v1,
  title = {Closed System Architectures for One Pot Molecular Diagnostics},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/closed-system-architectures-for-one-pot-molecular-diagnostics/rdr_0e43a30b98e64127954d3f2f99040948/v/1},
  note = {Version 1, frozen 2026-10-04. Accessed 2026-11-19},
}